are glp 1 drugs anti inflammatory Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Molecular signals underlying the anti-inflammatory

it does not directly modulate systemic hormonal axes in research models

A recent New England Journal of Medicine study showed that although both these new drugs are highly effective, tirzepatide was shown to be more effective for weight loss, possibly because of the combination of these two hormone agonists when compared to the single hormone agonist in semaglutide

ZEPBOUND has demonstrated greater weight loss than WEGOVY, giving it a commercial edge in GLP-1 weight loss research

Several drugs are in advanced clinical trials: In Phase III trials: IBI362 (Innovent/Eli Lilly), CagriSema (Novo Nordisk), Retatrutide (Eli Lilly), and Survodutide (Boehringer Ingelheim)